Real-World Study on Adjuvant Therapy Combined With Shenlingcao Oral Liquid in Patients for Stage II and IIIA Non-small Cell Lung Cancer After Radical Resection
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
West China Hospital
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Age 18 or older;
Pathological diagnosis of patients with stage II, III A primary NSCLC;
R0 resection has been accepted;
Received adjuvant chemotherapy or adjuvant chemotherapy for the first time after surgery;
Informed consent has been signed.
You may not be if
Incorporation of other malignant tumors (such as leukemia, liver cancer, etc.)；
Patients with unclear pathological types；
Patients with unclear pathological staging；
Preserved Shenlingcao Oral Liquid before R0 resection surgery；
Received immunotherapy or targeted therapy before R0 resection surgery；
Radiotherapy and chemotherapy before R0 resection surgery.
Clareo Health | Real-World Study on Adjuvant Therapy Combined With Shenlingcao Oral Liquid in Patients for Stage II and IIIA Non-small Cell Lung Cancer After Radical Resection
